CREWE ADVISORS LLC – Eli Lilly and Company Transaction History
CREWE ADVISORS LLC portfolio value:
$334,000
portfolio value
CREWE ADVISORS LLC quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +10.37% | 97 shares | 31K | $323.35 | 1.03K |
| Q2 2022 | share | Increase | +58.47% | 345 shares | 134K | $324.23 | 935 |
| Q1 2022 | share | 0.00% | 0 shares | 6K | $286.37 | 590 | |
| Q4 2021 | share | 0.00% | 0 shares | 27K | $277.25 | 590 | |
| Q3 2021 | share | 0.00% | 0 shares | 1K | $230.3 | 590 | |
| Q2 2021 | share | Increase | +9.26% | 50 shares | 34K | $228.04 | 590 |
| Q1 2021 | share | 0.00% | 0 shares | 10K | $184.81 | 540 | |
| Q4 2020 | share | Decrease | -5.59% | -32 shares | 6K | $166.32 | 540 |
| Q3 2020 | share | Increase | +30.00% | 132 shares | 13K | $145.05 | 572 |
| Q2 2020 | share | 0.00% | 0 shares | 11K | $160.1 | 440 | |
| Q1 2020 | share | 0.00% | 0 shares | 3K | $134.64 | 440 | |
| Q4 2019 | share | 0.00% | 0 shares | 9K | $126.91 | 440 | |
| Q3 2019 | share | 0.00% | 0 shares | 0 | $107.36 | 440 | |
| Q2 2019 | share | 0.00% | 0 shares | -8K | $105.74 | 440 | |
| Q1 2019 | share | 0.00% | 0 shares | 6K | $123.17 | 440 | |
| Q4 2018 | share | 0.00% | 0 shares | 4K | $109.26 | 440 | |
| Q3 2018 | share | 0.00% | 0 shares | 9K | $100.8 | 440 | |
| Q2 2018 | share | Decrease | -41.33% | -310 shares | -20K | $79.72 | 440 |
| Q1 2018 | share | Increase | +30.66% | 176 shares | 10K | $71.78 | 750 |
| Q4 2017 | share | Increase | 0.00% | 574 shares | 48K | $77.79 | 574 |